|
Aug 7
|
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 7
|
Biodesix Announces Second Quarter 2025 Results and Highlights
|
|
Aug 5
|
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference
|
|
Jul 25
|
Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers
|
|
Jul 25
|
Sangamo Therapeutics Announces Positive Phase 1/2 STAAR Study Results for Fabry Gene Therapy
|
|
Jul 24
|
Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025
|
|
Jun 10
|
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
|
|
May 22
|
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
|
|
May 22
|
Independent Director of Biodesix Picks Up 15% More Stock
|
|
May 12
|
Sonida Senior Living (SNDA) Reports Q1 Loss, Tops Revenue Estimates
|
|
Mar 3
|
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
|
|
Feb 26
|
Biodesix to Present at TD Cowen 45th Annual Health Care Conference
|
|
Oct 7
|
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
|
|
Jul 24
|
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
|
|
May 28
|
Biodesix to Participate in Two Investor Conferences in June
|
|
May 11
|
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price
|
|
May 10
|
Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
|
|
May 10
|
Biodesix First Quarter 2024 Earnings: Beats Expectations
|
|
May 9
|
Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
|